Erturhan Sakip, Erbagci Ahmet, Yagci Faruk, Celik Mehmet, Solakhan Mehmet, Sarica Kemal
Department of Urology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey.
Urology. 2007 Apr;69(4):633-6. doi: 10.1016/j.urology.2007.01.009.
To evaluate the activity of the therapeutic agents (tamsulosin and/or tolterodine) used to accelerate the expulsion of stones and to reduce the probable complications during observation of the medical treatment of distal ureteral stones to allow spontaneous passage.
A total of 120 patients with distal ureteral stones were included in the study. Patients with stones less than 10 mm and allowing urinary flow were included in the study. The patients were studied in four randomly divided groups. Group 1 patients received tamsulosin 0.4 mg/day, group 2 patients received tamsulosin 0.4 mg/day plus tolterodine 2 mg (twice a day), group 3 patients received tolterodine 2 mg (twice a day), and group 4 patients did not receive any medical treatment (control group).
Differences among the four groups in patient age and stone dimension were not statistically significant (P >0.05). The stone expulsion rates were greater (P <0.05) in groups 1 and 2 than in groups 3 and 4. A significant variation (P <0.05) regarding the time to stone expulsion was observed in groups 1 and 2.
In our study, the use of tamsulosin for the expulsion of distal ureteral stones was effective; however, the use of tolterodine provided no additional advantages.
评估用于加速结石排出并减少远端输尿管结石保守治疗观察期间可能出现的并发症的治疗药物(坦索罗辛和/或托特罗定)的活性,以促进结石自然排出。
本研究共纳入120例远端输尿管结石患者。纳入结石小于10mm且尿路通畅的患者。将患者随机分为四组。第1组患者接受坦索罗辛0.4mg/天,第2组患者接受坦索罗辛0.4mg/天加托特罗定2mg(每日两次),第3组患者接受托特罗定2mg(每日两次),第4组患者不接受任何药物治疗(对照组)。
四组患者的年龄和结石大小差异无统计学意义(P>0.05)。第1组和第2组的结石排出率高于第3组和第4组(P<0.05)。第1组和第2组在结石排出时间方面存在显著差异(P<0.05)。
在我们的研究中,使用坦索罗辛排出远端输尿管结石是有效的;然而,使用托特罗定并没有额外的优势。